Shares of CVS Health Corporation (NYSE:CVS – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the twenty-three brokerages that are covering the stock, MarketBeat reports. Four equities research analysts have rated the stock with a hold recommendation and nineteen have given a buy recommendation to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $94.8182.
A number of equities analysts have recently commented on CVS shares. Truist Financial set a $100.00 price objective on shares of CVS Health in a research report on Wednesday, December 10th. Piper Sandler reaffirmed an “overweight” rating and issued a $101.00 price target (up previously from $99.00) on shares of CVS Health in a report on Wednesday, December 10th. Mizuho lifted their price target on CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a research report on Wednesday, December 10th. UBS Group restated an “outperform” rating on shares of CVS Health in a research report on Wednesday, December 10th. Finally, Robert W. Baird raised their target price on shares of CVS Health from $82.00 to $92.00 and gave the company an “outperform” rating in a research note on Wednesday, December 10th.
Check Out Our Latest Stock Report on CVS
CVS Health Stock Up 1.2%
CVS Health Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.5%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s payout ratio is currently 700.00%.
Institutional Investors Weigh In On CVS Health
Large investors have recently added to or reduced their stakes in the company. ORG Partners LLC lifted its holdings in shares of CVS Health by 418.9% in the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 377 shares during the last quarter. Sound Income Strategies LLC lifted its stake in CVS Health by 32.3% in the second quarter. Sound Income Strategies LLC now owns 2,774 shares of the pharmacy operator’s stock worth $191,000 after purchasing an additional 677 shares during the last quarter. GC Wealth Management RIA LLC boosted its position in CVS Health by 34.3% during the second quarter. GC Wealth Management RIA LLC now owns 9,053 shares of the pharmacy operator’s stock valued at $624,000 after buying an additional 2,312 shares during the period. Mitsubishi UFJ Asset Management UK Ltd. grew its stake in shares of CVS Health by 16.7% during the second quarter. Mitsubishi UFJ Asset Management UK Ltd. now owns 21,000 shares of the pharmacy operator’s stock valued at $1,449,000 after buying an additional 3,000 shares during the last quarter. Finally, LBP AM SA increased its holdings in shares of CVS Health by 70.1% in the second quarter. LBP AM SA now owns 238,759 shares of the pharmacy operator’s stock worth $16,470,000 after buying an additional 98,429 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.
About CVS Health
CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.
Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.
Read More
- Five stocks we like better than CVS Health
- The day the gold market broke
- Forget AI, This Will Be the Next Big Tech Breakthrough
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Gold’s getting scarce.
- End of America Update
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
